An innovative approach to the treatment of insulin-dependent diabetes, the BPICS will use pancreatic islet cells to regulate blood sugar. Dr. Humes notes that cell therapy can control blood sugar via the natural biologic processes in which insulin production is regulated on a minute-to-minute basis in response to changes in blood glucose levels.

The BRECS system designed by our lab is intended as a major enabling technology for this and other cell therapy applications.

This effort is in pre-clinical development. No volunteers are needed.